Which sales, prescribing, and billing practices are red flags in an online GLP-1 provider?
Red flags for online GLP-1 providers include no live video consults, prescribing without labs, sourcing from unlicensed pharmacies, and unclear pricing.
Sales and Marketing Claims
Be wary of providers advertising "generic Wegovy" or "generic Ozempic." These do not exist. Similarly, claims of "FDA-approved compounded semaglutide" are false. Compounded medications are, by definition, not FDA-approved, as they are prepared in specific pharmacies to meet individual patient needs during shortages.
High-pressure sales tactics, countdown timers for "special offers," and guarantees of specific weight loss results are highly unprofessional. Clinical outcomes vary, and ethical medical practice focuses on patient health and safety, not on sales quotas or unrealistic promises.
A trustworthy provider's website should feature clear, evidence-based educational content. Reputable practices, like GOAL.MD, prioritize transparency about their clinical processes and licensed providers. You can learn more about our physician-led approach on our /about page.
Look for clear disclaimers about the status of compounded medications. If a provider is not upfront that these formulations lack FDA approval for safety and efficacy, consider it a significant red flag.
Prescribing and Clinical Process
A major red flag is prescribing medication without a real-time, synchronous consultation (e.g., a video call) with a licensed healthcare provider. Filling out an online form is not a substitute for a genuine patient-provider relationship and is often insufficient for safe prescribing.
The provider must require and review recent lab work before prescribing a GLP-1 medication. Essential tests like a Comprehensive Metabolic Panel (CMP) and HbA1c help determine if the medication is safe and appropriate for you. Prescribing without labs is dangerous.
You should be able to easily find your provider's name, credentials (MD, DO, NP, PA), and state license number. You can and should verify this information through your state's medical board licensing website or the Federation of State Medical Boards' lookup tool.
A thorough medical history intake is non-negotiable. The provider must screen for contraindications, including a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), pancreatitis, and other serious conditions.
Pharmacy Sourcing and Medication Quality
Your provider must be transparent about which pharmacy is supplying your medication. They should only use state-licensed pharmacies located within the United States. Refusal to name the pharmacy or using overseas suppliers is a critical warning sign.
The FDA has warned against using compounded semaglutide made with salt forms, such as semaglutide sodium and semaglutide acetate. These are different active ingredients than what is found in the FDA-approved drugs, and their safety and effectiveness have not been evaluated.
Legitimate providers will only use pharmacies that compound medications from a base form of the active pharmaceutical ingredient (API), as permitted during a drug shortage. Ask the provider to confirm the type of API used.
The medication should arrive with clear labeling that includes your name, the prescribing provider's name, the pharmacy's information, the drug name and strength, and instructions for use. Unlabeled or poorly labeled vials are unsafe and illegal.
Billing and Subscription Practices
Look for clear, upfront, and all-inclusive pricing. Hidden fees for shipping, supplies, or basic support are red flags. You should know exactly what you are paying for each month, including the medical consultation, medication, and ongoing care.
Beware of confusing subscription models or cancellation policies that are difficult to navigate. A reputable company will provide a straightforward way to manage or cancel your membership without punitive fees or complicated processes.
Check the provider's reputation on independent sites like the Better Business Bureau (BBB). A pattern of complaints related to billing disputes, unauthorized charges, or customer service issues is a strong indicator of a problematic company.
A provider certified by LegitScript has undergone a rigorous review of its legality, safety, and transparency. While not mandatory, this certification is a strong positive signal that the service adheres to high standards.
Bottom Line
Choosing an online GLP-1 provider requires careful evaluation. Prioritize physician-supervised programs that follow rigorous clinical safety protocols, use licensed U.S. pharmacies, and are transparent about their pricing and processes.
Key red flags to avoid are: no live video visit with a provider, prescribing without lab work, misleading marketing terms like "generic Ozempic," sourcing from unknown or foreign pharmacies, and opaque billing practices.
A trustworthy telehealth practice extends the standards of a traditional doctor's office to a virtual setting, establishing a valid patient-provider relationship built on safety and informed consent. Do not compromise on these standards for convenience or cost.
This is for educational purposes and is not medical advice. Consult a healthcare professional for any medical concerns.
Drafted by the GOAL.MD Authority Engine and approved editorially by GOAL.MD staff. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.